Cardiovascular Toxicology

, Volume 7, Issue 4, pp 255–263

Myocardial Fas Ligand Expression Increases Susceptibility to AZT-Induced Cardiomyopathy

  • Enkhsaikhan Purevjav
  • David P. Nelson
  • Jacquelin J. Varela
  • Shinawe Jimenez
  • Debra L. Kearney
  • Ximena V. Sanchez
  • Gilberto DeFreitas
  • Blasé Carabello
  • Michael D. Taylor
  • Matteo Vatta
  • William T. Shearer
  • Jeffrey A. Towbin
  • Neil E. Bowles
Article

DOI: 10.1007/s12012-007-9004-9

Cite this article as:
Purevjav, E., Nelson, D.P., Varela, J.J. et al. Cardiovasc Toxicol (2007) 7: 255. doi:10.1007/s12012-007-9004-9

Abstract

Background Dilated cardiomyopathy (DCM) and myocarditis occur in many HIV-infected individuals, resulting in symptomatic heart failure in up to 5% of patients. Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality of acquired immunodeficiency syndrome (AIDS), but has resulted in an increase in cardiac and skeletal myopathies. Methods and Results In order to investigate whether the HAART component zidovudine (3′-azido-2′,3′-deoxythymidine; AZT) triggers the Fas-dependent cell-death pathway and cause cytoskeletal disruption in a murine model of DCM, 8-week-old transgenic (expressing Fas ligand in the myocardium: FasL Tg) and non-transgenic (NTg) mice received water ad libitum containing different concentrations of AZT (0, 0.07, 0.2, and 0.7 mg/ml). After 6 weeks, cardiac function was assessed by echocardiography and morphology was assessed by histopathologic and immunohistochemical methods. NTg and untreated FasL Tg mice showed little or no change in cardiac structure or function. In contrast, AZT-treated FasL Tg mice developed cardiac dilation and depressed cardiac function in a dose-dependent manner, with concomitant inflammatory infiltration of both ventricles. These changes were associated with an increased sarcolemmal expression of Fas and FasL, as well as increased activation of caspase 3, translocation of calpain 1 to the sarcolemma and sarcomere, and increased numbers of cells undergoing apoptosis. These were associated with changes in dystrophin and cardiac troponin I localization, as well as loss of sarcolemmal integrity. Conclusions The expression of Fas ligand in the myocardium, as identified in HIV-positive patients, might increase the susceptibility to HAART-induced cardiomyopathy due to activation of apoptotic pathways, resulting in cardiac dilation and dysfunction.

Keywords

AZT Fas ligand Transgenic mice Apoptosis Cardiomyopathy 

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Enkhsaikhan Purevjav
    • 1
  • David P. Nelson
    • 1
  • Jacquelin J. Varela
    • 1
  • Shinawe Jimenez
    • 1
  • Debra L. Kearney
    • 2
  • Ximena V. Sanchez
    • 1
  • Gilberto DeFreitas
    • 3
  • Blasé Carabello
    • 3
  • Michael D. Taylor
    • 1
  • Matteo Vatta
    • 1
  • William T. Shearer
    • 4
  • Jeffrey A. Towbin
    • 1
    • 5
    • 6
  • Neil E. Bowles
    • 7
  1. 1.Department of Pediatrics, Section of CardiologyBaylor College of MedicineHoustonUSA
  2. 2.Department of Pathology, MedicineBaylor College of MedicineHoustonUSA
  3. 3.Department of General MedicineBaylor College of MedicineHoustonUSA
  4. 4.Department of Pediatrics, Section of Allergy and ImmunologyBaylor College of MedicineHoustonUSA
  5. 5.Department of Cardiovascular Sciences ProgramBaylor College of MedicineHoustonUSA
  6. 6.Department of Molecular and Human GeneticsBaylor College of MedicineHoustonUSA
  7. 7.Department of Pediatrics, Section of CardiologyUniversity of Utah School of Medicine, Eccles Institute of Human GeneticsSalt Lake CityUSA

Personalised recommendations